These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15637045)

  • 1. Infliximab-induced cerebral thrombophlebitis.
    Grange L; Nissen MJ; Garambois K; Dumolard A; Duc C; Gaudin P; Juvin R
    Rheumatology (Oxford); 2005 Feb; 44(2):260-1. PubMed ID: 15637045
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-induced systemic lupus erythematosus in ankylosing spondylitis associated with infliximab.
    Pérez-García C; Maymo J; Lisbona Pérez MP; Almirall Bernabé M; Carbonell Abelló J
    Rheumatology (Oxford); 2006 Jan; 45(1):114-6. PubMed ID: 16319096
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired erythrocytosis upon treatment with infliximab for ankylosing spondylitis.
    Antonelli M; Bupathi M; Janakiram M; Hergenroeder P; Khan MA
    J Rheumatol; 2011 Mar; 38(3):581-3. PubMed ID: 21362796
    [No Abstract]   [Full Text] [Related]  

  • 4. [Development of tuberculosis after treatment with the TNF-alpha inhibitor infliximab].
    Dahl M; Ravn P
    Ugeskr Laeger; 2005 Jan; 167(5):527-8. PubMed ID: 15745179
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
    van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J;
    Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab.
    Paschou S; Voulgari PV; Vrabie IG; Saougou IG; Drosos AA
    J Rheumatol; 2009 Feb; 36(2):351-4. PubMed ID: 19040305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and safety of treatment with infliximab in the elderly population.
    Chevillotte-Maillard H; Ornetti P; Mistrih R; Sidot C; Dupuis J; Dellas JA; Tavernier C; Maillefert JF
    Rheumatology (Oxford); 2005 May; 44(5):695-6. PubMed ID: 15705631
    [No Abstract]   [Full Text] [Related]  

  • 8. Exacerbation of infliximab-induced palmoplantar psoriasis under ustekinumab therapy in a patient with ankylosing spondylitis.
    Safa G; Martin A; Darrieux L
    J Clin Rheumatol; 2011 Oct; 17(7):385-6. PubMed ID: 21946468
    [No Abstract]   [Full Text] [Related]  

  • 9. Sézary syndrome in a patient receiving infliximab for ankylosing spondylitis.
    Dauendorffer JN; Rivet J; Allard A; Bachelez H
    Br J Dermatol; 2007 Apr; 156(4):742-3. PubMed ID: 17263820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy.
    Sanli H; Ataman S; Akay BN; Yilmaz A; Yildizlar D; Gürgey E
    J Drugs Dermatol; 2007 Aug; 6(8):834-6. PubMed ID: 17763616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study.
    Cantini F; Niccoli L; Benucci M; Chindamo D; Nannini C; Olivieri I; Padula A; Salvarani C
    Arthritis Rheum; 2006 Oct; 55(5):812-6. PubMed ID: 17013842
    [No Abstract]   [Full Text] [Related]  

  • 12. Paraparesis due to exacerbation of preexisting spinal pseudoarthrosis following infliximab therapy for advanced ankylosing spondylitis.
    Sakaura H; Hosono N; Mukai Y; Fujii R; Yoshikawa H
    Spine J; 2006; 6(3):325-9. PubMed ID: 16651229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study.
    Marzo-Ortega H; McGonagle D; Jarrett S; Haugeberg G; Hensor E; O'connor P; Tan AL; Conaghan PG; Greenstein A; Emery P
    Ann Rheum Dis; 2005 Nov; 64(11):1568-75. PubMed ID: 15829577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthenoazoospermia in patients receiving anti-tumour necrosis factor {alpha} agents.
    Montagna GL; Malesci D; Buono R; Valentini G
    Ann Rheum Dis; 2005 Nov; 64(11):1667. PubMed ID: 16227427
    [No Abstract]   [Full Text] [Related]  

  • 15. Tuberculous peritonitis.
    Finlay DG; Szauter K; Raju GS; Snyder N
    Am J Gastroenterol; 2005 Jul; 100(7):1624-5. PubMed ID: 15984997
    [No Abstract]   [Full Text] [Related]  

  • 16. Whole-body magnetic resonance imaging evaluation of widespread inflammatory lesions in a patient with ankylosing spondylitis before and after 1 year of treatment with infliximab.
    Appel H; Hermann KG; Althoff CE; Rudwaleit M; Sieper J
    J Rheumatol; 2007 Dec; 34(12):2497-8. PubMed ID: 18061968
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
    Braun J; Baraliakos X; Listing J; Fritz C; Alten R; Burmester G; Krause A; Schewe S; Schneider M; Sörensen H; Zeidler H; Sieper J
    Ann Rheum Dis; 2008 Mar; 67(3):340-5. PubMed ID: 17967831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis.
    Boonen A; van der Heijde D; Severens JL; Boendermaker A; Landewé R; Braun J; Brandt J; Sieper J; van der Linden S
    Ann Rheum Dis; 2006 Feb; 65(2):201-8. PubMed ID: 16014677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythema multiforme with tumour necrosis factor inhibitors: a class effect?
    Kain T; MacGregor D; Buchanan RR; de Jager JP; Schachna L
    Ann Rheum Dis; 2008 Jun; 67(6):899-900. PubMed ID: 18474663
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years.
    Braun J; Baraliakos X; Brandt J; Listing J; Zink A; Alten R; Burmester G; Gromnica-Ihle E; Kellner H; Schneider M; Sörensen H; Zeidler H; Sieper J
    Rheumatology (Oxford); 2005 May; 44(5):670-6. PubMed ID: 15757965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.